| Time(KST) | Program | ||
| 09:00-09:30 | Registration | ||
| 09:30-10:10 | Opening Remarks | ||
| 10:10-10:30 | Presentation Session 1 : Building a novel pandemic preparedness program | Speaker : Dr. Daniel Douek (NIAID,USA) | Chair: Woo-joo Kim, M.D., PhD. |
| 10:30-10:40 | Q&A | ||
| 10:40-11:00 | Presentation Session 2 : Development of therapeutic human monoclonal antibodies against SFTSV infection | Speaker : Dr. Han-saem Lee (NIID,Korea) | |
| 11:00-11:10 | Q&A | ||
| 11:10-11:30 | Presentation Session 3 : Bacteriophages and Endolysins Combating Multidrug Resistant (MDR) Pathogens | Speaker : Dr. Hee-joon Myung (LyseNTech,Korea) | Chair: Myoung-don Oh, M.D., PhD. |
| 11:30-11:40 | Q&A | ||
| 11:40-12:00 | Presentation Session 4 : NIH-Supported Clinical Trial of Phage Therapy for Cystic Fibrosis Begins | Speaker : Dr. Dennis Dixon (NIAID,USA) | |
| 12:00-12:10 | Q&A | ||
| 12:10-13:30 | Lunch | ||
| 13:30-13:50 | Presentation Session 5 : Flagellin as a potent immune modulator for the elderly | Speaker : Dr. Kyung-a Cho (Medispan Inc., Korea) | Chair: Baik-lin Seong, M.D., PhD. |
| 13:50-14:00 | Q&A | ||
| 14:00-14:20 | Presentation Session 6 : Vaccine adjuvants research | Speaker : Dr. Kentner Leroy Singleton (NIAID,USA) | |
| 14:20-14:30 | Q&A | ||
| 14:30-14:50 | Presentation Session 7 : The future of pandemic preparedness: Building collaborations and EV-D68 as a test case for NIAID/VRC's PREMISE program | Speaker : Dr. Alicen Spaulding (NIAID,USA) | |
| 14:50-15:00 | Q&A | ||
| 15:00-15:10 | Break | ||
| 15:10-15:40 | Panel Discussion | ||
| 15:40-17:10 | Meeting to Discuss Potential Collaborations | ||
| 17:10-18:10 | Break | ||
| 18:10- | Dinner | ||
| Meeting to Discuss Potential Collaborations (Expected participants) | |||
